MediPal Holdings Corporation (TYO:7459)

Market Cap	601.51B +8.4%
Revenue (ttm)	3.86T +4.2%
Net Income	46.59B +14.0%
EPS	227.21 +15.7%
Shares Out	204.70M
PE Ratio	12.93
Forward PE	13.25
Dividend	88.00 (3.02%)
Ex-Dividend Date	Sep 29, 2026

Volume	78,700
Open	2,965.00
Previous Close	2,938.50
Day's Range	2,919.50 - 2,973.50
52-Week Range	2,456.50 - 3,108.00
Beta	-0.02
Analysts	Hold
Price Target	2,950.00 (+0.7%)
Earnings Date	Nov 5, 2026

About MediPal Holdings

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,024
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.

Analyst Summary

According to 4 analysts, the average rating for 7459 stock is "Hold." The 12-month stock price target is ¥2,950, which is an increase of 0.70% from the latest price.

Price Target

¥2,950

(0.70% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error